Gastrointestinal lymphoma. Etiology, pathogenesis and therapy;Gastrointestinale lymphome. Atiologie, pathogenese und therapie

Internist

Volumn 41, Issue 9, 2000, Pages 831-840

  Fischbach, W ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PREDNISOLONE; VINCRISTINE;

BACTERIAL INFECTION; CANCER CHEMOTHERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOSCOPIC ECHOGRAPHY; ERADICATION THERAPY; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; INTESTINE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; REVIEW; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; EUROPE; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; PRACTICE GUIDELINES;

EID: 0033830497     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050635     Document Type: Review

References (62)

1. Primary malignant lymphoid tumors of the intestinal tract: Report of 37 cases with a study of factors influencing prognosis
2. Gastrointestinal involvement in Non-Hodgkin's lymphoma
3. Lymphomas of the gastrointestinal tract - A study of 117 cases presenting with gastrointestinal disease
4. Malignant lymphoma of mucosa associated lymphoid tissue
5. Classifying primary gut lymphomas
6. A revised European-American classification of lymphoid neoplasms. A proposal from the international lymphoma study group
7. World Health Organization classification of neoplastic diseases of hematopoetic and lymphoid tissues: Report of the clinical advisory committee meeting
8. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
9. Non-Hodgkin's Lymphoma of the gastrointestinal tract: A population-based analysis of the incidence, geographic distribution, clinicopathological presentation features, and prognosis
10. Primary lymphomas of the small intestine. A clinicopathological study of 119 cases
11. Lymphoid follicles in antral mucosa: Immune response to Campylobacter pylori?
12. Immune response of the gastric mucosa to Campylobacter pylori
13. Helicobacter pylori gastritis and gastric MALT-lymphoma
14. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
15. Helicobacter pylori gastritis and gastric nonhodgkin's lymphoma
16. MALT-type lymphoma of the stomach is associated YAM Helicobacter pylori strains expressing the CagA protein
17. High incidence of primary gastric lymphoma in northeastern Italy
18. Helicobacter pylori infection and gastric lymphoma
19. MALToma-like lesions in the stomach resulting from longstanding Helicobacter infection in the mouse
20. Mouse to mouse resuscitation of low-grade MALT lymphoma induced by prolonged Helicobacter infection. A preliminary study of transplanted tumors
21. Idiotype identity in a MALT-type lymphoma and B-cells in Helicobacter pylori associated chronic gastritis
22. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
23. Helicobacter pylori specific tumour infiltrating T-cells provide contact dependent help for the growth of malignant B-cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue
24. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant Non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-type)
25. A comparison of Helicobacter pylori and H. hellmannii gastritis. A matched control study involving 404 patients
26. Primary B-cell gastric lymphoma: A clinicopathological study of 145 patients
27. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue. Factors relevant to prognosis
28. Diagnostische aussagekraft der magenbiopsie im vergleich zum resektat bei primaren gastralen B-zell-lymphomen vom MALT-typ
29. Role of endoscopic ultrasound (EUS)in local staging of primary gastric lymphoma: Results of the German-Austrian prospective multicenter study
30. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
31. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
32. Cure of Helicobacter pylori infection in 125 patients with primary gastric low-grade MALT lymphoma
33. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
34. Long-term effect of anti-Helicobacter pylori therapy on gastric MALT lymphoma. Histological and molecular evaluation of 15 cases
35. Helicobacter pylori eradication for the treatment of low-grade gastric MALT-lymphoma: Follow-up together with sequential molecular studies
36. Histology and stage stratified therapy offers promising results in primary gastric non-Hodgkin's lymphoma: Experiences of the German-Austrian prospective multicenter trial
37. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: A study controlled by endoscopic ultrasound
38. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
39. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
40. Is there an obligatory need for an oncological treatment modality if Hellicobacter pylori eradication is not followed by complete regression of gastric low-grade lymphoma or MALT-type?
41. A pitfall in assessing gastric lymphoma after eradication of Helicobacter pylori
42. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: Differences between histologic and serologic diagnosis
43. Gastric B-cell mucosa-associated lymphoid tissue (MALT): Clinocopathological study and evaluation of the prognostic factors in 143 patients
44. Role of surgery in multimodality therapy for gastrointestinal lymphoma
45. Primary gastric lymphomas: A clinicopathologic study with literature review
46. Total gastrotomy for primary gastric lymphoma at stages IE and IIE: A prospective study of fifty cases
47. Treatment and prognosis of gastric lymphoma
48. Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: An old problem revisited
49. Primary digestive tract lymphoma: A prospective multicentric study of 91 patients
50. Diagnostik und therapie des primaren magenlymphoms
51. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature
52. Intermediate and high-grade gastric non-Hodgkin's lymphoma: A prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy
53. Primary lymphoma of the stomach: Three-year results of a prospective multicenter study
54. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma
55. Stomach preservation in low- and high-grade primary gastric lymphomas: Preliminary results
56. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone
57. Gastric lymphomas: Chemotherapy as a primary treatment
58. Kombinierte konservative behandlung von lokalisierten magenlymphomen
59. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach
60. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori
61. Multiple lymphomatous polyposis of the gastrointestinal tract: Prospective clinicopathologic study of 31 cases
62. Rituximab in the treatment of gastrointestinal (GI) mucosaassociated lymphoid tissue (MALT) lymphoma